Clinical Trial Research
CEL-SCI Receives Key Chinese Patent for Its Investigational Cancer Therapy Multikine Leukocyte Interleukin, Injection
Published in Clinical Trials Week, August 29th, 2011
This invention relates to a novel investigational therapy that CEL-SCI believes has the potential to be a method for pre-sensitizing cancer with Multikine (Leukocyte Interleukin, Injection) prior to a therapeutic treatment such as chemotherapy, radiation therapy...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2011-08-29)
More Articles from Clinical Trials Week
- Drug Development
AMRI Receives NIH Contract Award for the Development of Pre-Clinical Drug Candidates to Treat Diseases of the Nervous System - U.S. Food and Drug Administration
CEL-SCI Addresses Warning Letter in Regard to Statements on Its Corporate Website - Hepatitis C Virus
Data on Hepatitis C Virus Discussed by L. Castells and Colleagues - Thalidomide Therapy
Data on Thalidomide Therapy Reported by E.A. Wilkes and Co-Researchers - Protein Engineering
Dual-action protein developed at Stanford better restricts blood vessel formation - Clinical Trial Research
Findings from Rush University Advance Knowledge in Clinical Trial Research - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
